MTOR and acute myeloid leukemia: In AML patients, uncontrolled malignant cell growth often arises from disruption in intracellular signaling caused by mutations or aberrant external signaling, and aberrant upregulation of the mTOR pathway has been observed in patients with AML (64–66).